Different effects of estradiol and various antiestrogens on TNF-α-induced changes of biochemical markers for growth and invasion of human breast cancer cells

Life Sciences

Volumn 78, Issue 13, 2006, Pages 1464-1468

  Seeger, H ^a   Wallwiener, D ^a   Mueck, A O ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

2 Methoxyestradiol; Estradiol; Growth; Human breast cancer cells; Invasion; Tamoxifen; TNF

Indexed keywords

2 METHOXYESTRADIOL; ANTIESTROGEN; BIOLOGICAL MARKER; CHEMOKINE; ESTRADIOL; GELATINASE B; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TAMOXIFEN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; HORMONAL THERAPY; HUMAN; HUMAN CELL; INCUBATION TIME; METASTASIS; PROTEIN SYNTHESIS; TUMOR CELL; TUMOR GROWTH;

APOPTOSIS; BREAST NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; ESTRADIOL; ESTROGEN RECEPTOR MODULATORS; FEMALE; HUMANS; INTERLEUKIN-8; NEOPLASM INVASIVENESS; TAMOXIFEN; TUMOR MARKERS, BIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

MINK CELL FOCUS-FORMING VIRUS;

EID: 32544450179     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2005.07.042     Document Type: Article

References (31)

1. M. Bar-Eli Role of interleukin-8 in tumor growth and metastasis in human melanoma Pathobiology 67 1999 3 18
2. E.A. Carswell, L.J. Old, R.I. Kassel, S. Green, N. Fiore, and B. Williamson An endotoxin-induced serum factor that causes necrosis of tumours Proceedings of the National Academy of Sciences of the United States of America 72 1975 3666 3670
3. A. Freund, C. Chauveau, J.P. Brouillet, A. Lucas, M. Lacroix, A. Licznar, F. Vignon, and G. Lazennec IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells Oncogene 22 2003 256 265
4. D.R. Green, V.L. Green, M.C. White, and V. Speirs Expression of cytokine messenger RNA in normal and neoplastic human breast tissue: identification of interleukin-8 as a potential regulatory factor in breast cancer International Journal of Cancer 72 1997 937 941
5. T. Hagemann, S.C. Robinson, M. Schulz, L. Trümper, F.R. Balkwill, and C. Binder Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-α dependent up-regulation of matrix metalloproteases Carcinogenesis 25 2004 1543 1549
6. J.H. Harmey, and D. Bouchier-Hayes Vascular endothelial growth factor (VEGF), a survival factor for tumor cells: implications for anti-angiogenic therapy BioEssays 24 2002 280 283
7. L. Holmberg, and H. Anderson HABITS steering and data monitoring committees, 2004. HABITS (hormonal replacement therapy after breast cancer-is it safe?), a randomised comparison: trial stopped Lancet 363 2004 453 455
8. H. Inadera, T. Sekiya, T. Yoshimura, and K. Matsushima Molecular analysis of the inhibition of monocyte chemoattractant protein-1 gene expression by estrogens and xenoestrogens in MCF-7 cells Endocrinology 141 2000 50 59
9. N.J. Lakhani, M.A. Sarkar, J. Venitz, and W.D. Figg 2-Methoxyestradiol, a promising anticancer agent Pharmacotherapy 23 2003 165 172
10. T.M. Leber, and F.R. Balkwill Regulation of monocyte MMP-9 production by TNF-alpha and a tumour-derived soluble factor (MMPSF) British Journal of Cancer 78 1998 724 732
11. Y. Lin, R. Huang, L. Chen, S. Li, Q. Shi, C. Jordan, and R.-P. Huang Identification of interleukin-8 as estrogen receptor-regulated factor involved in breast cancer invasion and angiogenesis by protein arrays International Journal of Cancer 109 2004 507 514
12. L.A. Liotta, and W.G. Stetler-Stevenson Tumor invasion and metastasis: an imbalance of positive and negative regulation Cancer Research 51 1991 5054s 5059s
13. C. Lippert, H. Seeger, A.O. Mueck, and T.H. Lippert The effects of A-ring and D-ring metabolites of estradiol on the proliferation of vascular endothelial cells Life Sciences 67 2000 1653 1658
14. N.J. Mabjeesh, D. Escuin, T.M. LaVallee, V.S. Pribluda, G.M. Swartz, M.S. Johnson, M.T. Willard, H. Zhong, J.W. Simons, and P. Giannakakou 2ME2 inhibits tumor growth and angiogenesis by disrupting mictrotubules and dysregulating HIF Cancer Cell 3 2003 363 375
15. S.T.A. Malik, S. Naylor, N. East, A. Oliff, and F.R. Balkwill Cells secreting tumor necrosis factor show enhanced metastasis in nude mice European Journal of Cancer 26 1990 1031 1034
16. A. Mantovani Tumor-associated macrophages in neoplastic progression: a paradigm for the in vivo function of chemokines Laboratory Investigations 71 1994 5 16
17. K. Matsushima, C.G. Larsen, G.C. DuBois, and J.J. Oppenheim Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human monocytic cell line Journal of Experimental Medicine 169 1989 1485 1490
18. R.J. Moore, D.M. Owens, G. Stamp, C. Arnott, F. Burke, N. East, H. Holdswoth, L. Turner, B. Rollins, M. Pasparakis, G. Kollias, and F. Balkwill Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis Nature Medicine 5 1999 828 831
19. A.O. Mueck, H. Seeger, and J. Huober Chemotherapy of breast cancer-additive anticancerogenic effect by 2-methoxyestradiol? Life Sciences 75 2004 1205 1210
20. A.O. Mueck, H. Seeger, D. Wallwiener, and J. Huober Is the combination with 2-methoxy-estradiol able to reduce the dosages of chemotherapeutics in treatment on human ovary cancer? European Journal of Gynecological Oncology 25 2004 699 701
21. K. Nanda, L.A. Bastian, and K. Schultz Hormone replacement therapy and the risk of death from breast cancer: a systematic review American Journal of Obstetrics and Gynecology 186 2002 325 334
22. M. Nesbit, H. Schaider, T.H. Miller, and M. Herlyn Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells Journal of Immunology 166 2001 6483 6490
23. J.J. Oppenheim, C.O.C. Zachariae, N. Mukaida, and K. Matsushuma Properties of the novel proinflammatory supergene "intercrine" cytokine family Annual Reviews of Immunology 9 1991 617 648
24. P. Orosz, A. Kruger, M. Hubbe, J. Ruschoff, P. Von Hoegen, and D.N. Mannel Promotion of experimental liver metastasis by tumor necrosis factor International Journal of Cancer 60 1995 867 871
25. D.J. Price, T. Miralem, S. Jiang, R. Steinberg, and H. Avraham Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells Cell Growth and Differentiation 12 2001 129 135
26. S.C. Robinson, K.A. Scott, and F.R. Balkwill Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-α European Journal of Immunology 32 2002 404 412
27. B.J. Rollins Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease Molecular Medicine Today 2 1996 198 204
28. H. Seeger, F.U. Deuringer, D. Wallwiener, and A.O. Mueck Breast cancer risk during HRT: influence of estradiol metabolites on breast cancer and endothelial cell proliferation Maturitas 49 2004 235 240
29. The Women's Health Initiative Steering Committee Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The Women's Health Initiative Randomised Controlled Trial Journal of the American Medical Association 291 2004 1701 1712
30. E. von Schoultz, L.E. Rutqvist Stockholm Breast Cancer Study Group Menopausal hormone therapy after breast cancer: the Stockholm randomized trial Journal of the National Cancer Institute 97 2005 533 535
31. Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women Journal of the American Medical Association 288 2002 321 333